Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

CV Sciences Shares Outstanding 2011-2024 | CVSI

CV Sciences shares outstanding from 2011 to 2024. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  
CV Sciences Annual Shares Outstanding
(Millions of Shares)
2023 154
2022 138
2021 108
2020 100
2019 98
2018 114
2017 80
2016 53
2015 35
2014 32
2013 10
2012 7
2011 7
2010 5
CV Sciences Quarterly Shares Outstanding
(Millions of Shares)
2024-06-30 172
2024-03-31 163
2023-12-31 154
2023-09-30 155
2023-06-30 153
2023-03-31 152
2022-12-31 138
2022-09-30 147
2022-06-30 135
2022-03-31 117
2021-12-31 108
2021-09-30 109
2021-06-30 108
2021-03-31 105
2020-12-31 100
2020-09-30 100
2020-06-30 100
2020-03-31 100
2019-12-31 98
2019-09-30 99
2019-06-30 121
2019-03-31 95
2018-12-31 114
2018-09-30 116
2018-06-30 112
2018-03-31 96
2017-12-31 80
2017-09-30 88
2017-06-30 83
2017-03-31 60
2016-12-31 53
2016-09-30 52
2016-06-30 52
2016-03-31 50
2015-12-31 35
2015-09-30 35
2015-06-30 35
2015-03-31 34
2014-12-31 32
2014-09-30 33
2014-06-30 33
2014-03-31 26
2013-12-31 10
2013-09-30 10
2013-06-30 9
2013-03-31 8
2012-12-31 7
2012-09-30 7
2012-06-30 7
2012-03-31
2011-12-31 7
2011-09-30 7
2011-06-30 7
2011-03-31 7
2010-12-31
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.008B $0.016B
CV Sciences Inc. is a life science company. Its operating segment consists of specialty pharmaceuticals and consumer products. Specialty pharma business segment is focused on developing and commercializing therapeutics utilizing synthetic Cannabidiol across several therapeutic areas. Consumer product business segment is focused on manufacturing, marketing and selling plant-based CBD products. It operates primarily in San Diego, California and Las Vegas, Nevada. CV Sciences Inc. is based in Las Vegas, United States.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $79.473B 30.58
Takeda Pharmaceutical (TAK) Japan $43.433B 9.04
Merck (MKKGY) Germany $20.989B 22.91
Astellas Pharma (ALPMY) Japan $20.286B 18.68
Sandoz Group AG (SDZNY) Switzerland $19.912B 0.00
United Therapeutics (UTHR) United States $17.877B 17.59
Summit Therapeutics (SMMT) United States $16.054B 0.00
Neurocrine Biosciences (NBIX) United States $12.876B 34.09
Shionogi (SGIOY) Japan $12.330B 11.81
Catalent (CTLT) United States $10.793B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.685B 7.52
Madrigal Pharmaceuticals (MDGL) United States $7.408B 0.00
Orion OYJ (ORINY) Finland $6.848B 19.25
Corcept Therapeutics (CORT) United States $6.188B 46.87
Ionis Pharmaceuticals (IONS) United States $6.139B 0.00
Crinetics Pharmaceuticals (CRNX) United States $4.803B 0.00
PTC Therapeutics (PTCT) United States $3.461B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.848B 17.04
Dyne Therapeutics (DYN) United States $2.824B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.797B 12.68
Arrowhead Pharmaceuticals (ARWR) United States $2.731B 0.00
Soleno Therapeutics (SLNO) United States $2.552B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.213B 0.00
Recursion Pharmaceuticals (RXRX) United States $2.204B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.896B 0.00
Harrow (HROW) United States $1.846B 0.00
Evotec AG (EVO) Germany $1.726B 0.00
Ocular Therapeutix (OCUL) United States $1.709B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.696B 0.00
ARS Pharmaceuticals (SPRY) United States $1.696B 0.00
Xencor (XNCR) United States $1.631B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.569B 0.00
Indivior (INDV) United States $1.449B 5.90
Guardian Pharmacy Services (GRDN) United States $1.382B 0.00
Enliven Therapeutics (ELVN) United States $1.305B 0.00
Cassava Sciences (SAVA) United States $1.302B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.216B 0.00
Ardelyx (ARDX) United States $1.159B 0.00
Collegium Pharmaceutical (COLL) United States $1.038B 5.67
Bioventus (BVS) United States $1.007B 31.90
Relay Therapeutics (RLAY) United States $0.825B 0.00
USANA Health Sciences (USNA) United States $0.787B 14.59
Ironwood Pharmaceuticals (IRWD) United States $0.764B 0.00
Exscientia (EXAI) United Kingdom $0.757B 0.00
Cronos Group (CRON) Canada $0.753B 0.00
Tourmaline Bio (TRML) United States $0.726B 0.00
Korro Bio (KRRO) United States $0.683B 0.00
Savara (SVRA) United States $0.670B 0.00
ProKidney (PROK) United States $0.623B 0.00
Larimar Therapeutics (LRMR) United States $0.593B 0.00
Elite Pharmaceuticals (ELTP) United States $0.578B 54.10
OmniAb (OABI) United States $0.544B 0.00
Verve Therapeutics (VERV) United States $0.544B 0.00
Siga Technologies (SIGA) United States $0.538B 6.28
Silence Therapeutics (SLN) United Kingdom $0.525B 0.00
Altimmune (ALT) United States $0.522B 0.00
Esperion Therapeutics (ESPR) United States $0.497B 0.00
Xeris Biopharma Holdings (XERS) United States $0.489B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.482B 0.00
KalVista Pharmaceuticals (KALV) United States $0.479B 0.00
Zevra Therapeutics (ZVRA) United States $0.471B 0.00
Organogenesis (ORGO) United States $0.464B 0.00
Aquestive Therapeutics (AQST) United States $0.462B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.444B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.439B 178.21
Akebia Therapeutics (AKBA) United States $0.434B 0.00
4D Molecular Therapeutics (FDMT) United States $0.419B 0.00
Sage Therapeutics (SAGE) United States $0.385B 0.00
Lyell Immunopharma (LYEL) United States $0.338B 0.00
Aldeyra Therapeutics (ALDX) United States $0.327B 0.00
Nature's Sunshine Products (NATR) United States $0.322B 19.15
Avita Medical (RCEL) United States $0.320B 0.00
Pyxis Oncology (PYXS) United States $0.282B 0.00
Heron Therapeutics (HRTX) United States $0.279B 0.00
Lexeo Therapeutics (LXEO) United States $0.263B 0.00
Acrivon Therapeutics (ACRV) United States $0.255B 0.00
Nektar Therapeutics (NKTR) United States $0.253B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.230B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.226B 0.00
Profound Medical (PROF) Canada $0.201B 0.00
Nanobiotix S.A (NBTX) France $0.191B 0.00
Aclaris Therapeutics (ACRS) United States $0.188B 0.00
MediWound (MDWD) Israel $0.188B 0.00
Incannex Healthcare (IXHL) Australia $0.187B 0.00
Galectin Therapeutics (GALT) United States $0.180B 0.00
Cardiol Therapeutics (CRDL) Canada $0.157B 0.00
CytoDyn (CYDY) United States $0.154B 0.00
Achieve Life Sciences (ACHV) Canada $0.154B 0.00
Context Therapeutics (CNTX) United States $0.153B 0.00
Telomir Pharmaceuticals (TELO) United States $0.130B 0.00
Century Therapeutics (IPSC) United States $0.125B 0.00
VAXART, INC (VXRT) United States $0.123B 0.00
Fractyl Health (GUTS) United States $0.120B 0.00
OptiNose (OPTN) United States $0.116B 0.00
Journey Medical (DERM) United States $0.116B 0.00
Karyopharm Therapeutics (KPTI) United States $0.116B 0.00
Innate Pharma SA (IPHYF) France $0.103B 0.00
Relmada Therapeutics (RLMD) United States $0.098B 0.00
Arch Biopartners (ACHFF) Canada $0.093B 0.00
Regulus Therapeutics (RGLS) United States $0.092B 0.00
PMV Pharmaceuticals (PMVP) United States $0.091B 0.00
Assertio Holdings (ASRT) United States $0.088B 23.12
Inotiv (NOTV) United States $0.087B 0.00
CASI Pharmaceuticals (CASI) China $0.086B 0.00
ElectroCore (ECOR) United States $0.086B 0.00
AlloVir (ALVR) United States $0.085B 0.00
Citius Pharmaceuticals (CTXR) United States $0.081B 0.00
ESSA Pharma (EPIX) Canada $0.079B 0.00
Metagenomi (MGX) United States $0.078B 0.00
Swiftmerge Acquisition (IVCP) United States $0.076B 368.67
Vivani Medical (VANI) United States $0.070B 0.00
Prelude Therapeutics (PRLD) United States $0.065B 0.00
Mural Oncology (MURA) Ireland $0.062B 0.00
Champions Oncology (CSBR) United States $0.061B 0.00
Gain Therapeutics (GANX) United States $0.055B 0.00
Nutriband (NTRB) United States $0.054B 0.00
Protara Therapeutics (TARA) United States $0.053B 0.00
Unicycive Therapeutics (UNCY) United States $0.050B 0.00
SCYNEXIS (SCYX) United States $0.049B 0.00
Rafael Holdings (RFL) United States $0.046B 0.00
VYNE Therapeutics (VYNE) United States $0.045B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.044B 0.00
Carisma Therapeutics (CARM) United States $0.042B 0.00
DURECT (DRRX) United States $0.040B 0.00
BioLineRx (BLRX) Israel $0.036B 0.00
FibroGen (FGEN) United States $0.034B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.034B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.033B 0.00
Oruka Therapeutics (ORKA) United States $0.032B 0.00
Iterum Therapeutics (ITRM) Ireland $0.032B 0.00
Surrozen (SRZN) United States $0.031B 0.00
Lipocine (LPCN) United States $0.029B 0.00
BioVie (BIVI) United States $0.028B 0.00
Tempest Therapeutics (TPST) United States $0.028B 0.00
Natural Alternatives (NAII) United States $0.027B 0.00
GlycoMimetics (GLYC) United States $0.027B 0.00
Enlivex Therapeutics (ENLV) Israel $0.026B 0.00
Inhibikase Therapeutics (IKT) United States $0.021B 0.00
MEI Pharma (MEIP) United States $0.021B 0.73
Tonix Pharmaceuticals Holding (TNXP) United States $0.019B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.018B 0.00
TherapeuticsMD (TXMD) United States $0.018B 0.00
Lyra Therapeutics (LYRA) United States $0.017B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.017B 0.00
PolyPid (PYPD) Israel $0.017B 0.00
Cosmos Health (COSM) United States $0.016B 0.00
Minerva Neurosciences (NERV) United States $0.016B 0.00
Vivos Therapeutics (VVOS) United States $0.015B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.015B 0.00
Talphera (TLPH) United States $0.015B 0.00
Mannatech (MTEX) United States $0.015B 0.00
Scienture Holdings (SCNX) United States $0.014B 0.00
ProPhase Labs (PRPH) United States $0.014B 0.00
Avalo Therapeutics (AVTX) United States $0.014B 0.00
NRx Pharmaceuticals (NRXP) United States $0.014B 0.00
Nuvilex (PMCB) United States $0.014B 0.00
Indaptus Therapeutics (INDP) United States $0.012B 0.00
Addex Therapeutics (ADXN) Switzerland $0.011B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.011B 0.00
Dominari Holdings (DOMH) United States $0.011B 0.00
Redhill Biopharma (RDHL) Israel $0.010B 0.00
Traws Pharma (TRAW) United States $0.010B 0.00
Conduit Pharmaceuticals (CDT) United States $0.010B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.010B 0.00
Jaguar Animal Health (JAGX) United States $0.009B 0.00
Viracta Therapeutics (VIRX) United States $0.007B 0.00
Plus Therapeutics (PSTV) United States $0.007B 0.00
TransCode Therapeutics (RNAZ) United States $0.007B 0.00
Aptorum Group (APM) United Kingdom $0.007B 0.00
Biomerica (BMRA) United States $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Klotho Neurosciences (KLTO) United States $0.006B 0.00
Mangoceuticals (MGRX) United States $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.004B 0.00
Ainos (AIMD) United States $0.004B 0.00
TNF Pharmaceuticals (TNFA) United States $0.004B 0.00
SHINECO (SISI) China $0.004B 0.00
Oncternal Therapeutics (ONCT) United States $0.004B 0.00
Heatwurx (PCSA) United States $0.004B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.003B 0.00
Alaunos Therapeutics (TCRT) United States $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.003B 0.00
Petros Pharmaceuticals (PTPI) United States $0.003B 0.00
Avenue Therapeutics (ATXI) United States $0.003B 0.08
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
Clearmind Medicine (CMND) Canada $0.003B 0.00
SciSparc (SPRC) Israel $0.002B 0.00
Bio-Path Holdings (BPTH) United States $0.002B 0.00
Molecular Templates (MTEM) United States $0.002B 0.00
Phio Pharmaceuticals (PHIO) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
China SXT Pharmaceuticals (SXTC) China $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.002B 0.00
Aditxt (ADTX) United States $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.001B 0.00
Universe Pharmaceuticals INC (UPC) China $0.001B 0.00
PainReform (PRFX) Israel $0.000B 0.00
CERo Therapeutics Holdings (CERO) United States $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 2.98
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 41.74